viewHorizon Discovery Group PLC

Horizon Discovery Gp - Block Listing Six Monthly Return

RNS Number : 1517U
Horizon Discovery Group plc
27 July 2020

Horizon Discovery Group plc

27 July 2020



Horizon Discovery Group plc

Block Listing Six Monthly Return

27 July 2020: Horizon Discovery Group plc (LSE: HZD) ("Horizon") provides the following update in accordance with Schedule Six of the AIM Rules for Companies regarding its existing block listing arrangements:

Name of applicant:

Horizon Discovery Group plc


Name of scheme(s):

a)   Horizon Discovery Limited Enterprise Management Incentive Share Option Scheme

b)   Horizon Discovery Group plc Long Term Incentive Plan

c)   Horizon Discovery 2014 Sharesave Scheme

d)   Horizon Discovery Group plc US Employee Stock Purchase Plan


Period of return (from / to):

From 26 January 2020 to 25 July 2020

Number of securities admitted and date of admission

Total of 3,000,000 ordinary shares of 1p each, admission date 26 July 2017, split:

a)   1,398,000 

b)   1,392,000

c)   110,000

d)   100,000

Further 500,000 ordinary shares of 1p each, admission date 27 July 2018, split:

a) 0

b) 150,000

c) 150,000

d) 200,000

Further 1,500,000 ordinary shares of 1p each, admission date 28 October 2019, split:

a) 0

b) 500,000

c) 500,000

d) 500,000


Balance of unallotted securities under schemes from previous return:

Total of 2,983,644 ordinary shares of 1p each, split:

a) 602,425

b) 1,352,676

c) 567,971

d) 460,572


Less: Number of securities issued/allotted under scheme(s) during period:

Total of 534,264 ordinary shares of 1p each, split:

a) 478,340

b) 52,760

c) 3,164

d) 0


Equals: Balance under scheme(s) not yet issued/allotted at end of period:

Total of 2,449,380 ordinary shares of 1p each, split:

a) 124,085

b) 1,299,916

c) 564,807

d) 460,572




For further information from Horizon Discovery Group plc, please contact:

Horizon Discovery Group plc

Terry Pizzie, Chief Executive Officer

Jayesh Pankhania, Chief Financial Officer

Jon Davies, Head of Investor Relations

Tel: +44 (0) 1223 655 580


Numis Securities Limited (Broker and NOMAD)

Freddie Barnfield/Duncan Monteith

Tel: +44 (0) 207 260 1000


Consilium Strategic Communications (UK Financial Media and Investor Relations)

Mary-Jane Elliott / Matthew Neal / Melissa Gardiner

Tel: +44 (0) 20 3709 5700

Email: [email protected]


Westwicke, an ICR Company (US Investor Relations)

Stephanie Carrington

Tel. +1 646-277-1282

Email: [email protected]


About Horizon Discovery Group plc www.horizondiscovery.com

Horizon Discovery Group plc (LSE: HZD) ("Horizon") is a cell engineering company focused on commercialising the application of gene editing and gene modulation to accelerate scientific innovation and biopharmaceutical drug development. Horizon's portfolio of tools and services is built on decades of experience in altering the expression of genes across mammalian and human cell types to provide cell engineering tools and services to customers in three key areas of the therapeutic ecosystem: basic research, drug discovery and development and therapeutic applications. Horizon's offerings support and enable critical elements of the drug development and therapeutic value chain, particularly in the area of precision medicine. Horizon's customers include biopharmaceutical and diagnostics companies, contract research and manufacturing organisations and academic researchers across the globe.

Horizon is headquartered in Cambridge, UK with offices in USA and Japan.  The Group is listed on the London Stock Exchange's AIM market under the ticker HZD.



This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

Quick facts: Horizon Discovery Group PLC

Price: 90.2

Market: AIM
Market Cap: £142.49 m

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...


Acquisition gives Horizon Discovery a 'full and complete suite of tools' to...

Chris Claxton, VP Investor Relations & Corporate Communications at Horizon Discovery Group PLC (LON:HZD), discusses with Proactive their 'transformational' acquisition of GE healthcare business Dharmacon. The US$85mln deal was announced in July and funded through cash and shares and...

on 4/9/17

4 min read